Impact of Indinavir on the Quality of Life in Patients with Advanced HIV Infection Treated with Zidovudine and Lamivudine | Zendy

Paul Coplan | Zendy; J.R. Cook | Zendy; George W. Carides | Zendy; Joseph F. Heyse | Zendy; Albert W. Wu | Zendy; Scott M. Hammer | Zendy; Bach Nguyen | Zendy; Anne R. Meibohm | Zendy; Mark J. DiNubile | Zendy

Open Access

Impact of Indinavir on the Quality of Life in Patients with Advanced HIV Infection Treated with Zidovudine and Lamivudine

Author(s) -

Paul Coplan,

J.R. Cook,

George W. Carides,

Joseph F. Heyse,

Albert W. Wu,

Scott M. Hammer,

Bach Nguyen,

Anne R. Meibohm,

Mark J. DiNubile

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/422520

Subject(s) - indinavir , zidovudine , lamivudine , medicine , stavudine , reverse transcriptase inhibitor , quality of life (healthcare) , visual analogue scale , immunology , oncology , viral load , surgery , viral disease , human immunodeficiency virus (hiv) , virus , antiretroviral therapy , hepatitis b virus , nursing

In AIDS Clinical Trial Group (ACTG) study 320, triple-combination antiretroviral therapy including indinavir significantly slowed progression to acquired immunodeficiency syndrome or death, compared with treatment with dual nucleoside reverse-transcriptase inhibitors (NRTIs) alone, in zidovudine-experienced patients with advanced human immunodeficiency virus (HIV) infection. We examined the impact of indinavir on quality of life in participants from this study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research